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ABSTRACT 
 
The purpose of this research was to determine the viability of using instrumental 
neutron activation analysis (INAA) to quantify silver nanoparticle (AgNP) content in 
biological matrices in the context of pathology evaluations of silver-eluting devices for 
United States Food and Drug Administration (FDA) approval. This work was comprised 
of feasibility, experimental, and simulation stages. 
The extent of how AgNPs presented through transmission electron microscopy 
(TEM), scanning electron microscopy (SEM) with energy-dispersive X-ray 
microanalysis (EDX), and INAA methodologies within porcine skin was explored in the 
feasibility trial. Sections of skin containing control and test articles were investigated 
using these modalities. The control article was skin that contained a driveline coated in 
material known to elute AgNPs into tissue. TEM findings supported the conclusion that 
the host reacted to the presence of larger AgNP aggregates surrounding the control 
article at an ultrastructural level. The test article was skin that contained a driveline 
coated in material hypothesized to not elute AgNPs into surrounding tissue. AgNPs were 
not observed to aggregate throughout the tissue adjacent to the test article, and a marked 
host reaction to their presence was not observed. INAA results correlated with these 
findings; silver was not detected adjacent to the test article, but a concentration of 74 
ppm ± 29% of silver was observed in tissue adjacent to the control article. 
A complex system of ordinary differential equations (ODEs) was constructed to 
determine the inventory of the activation and subsequent decay progeny produced in a 
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sample containing silver exposed to a neutron field. These ODEs were constructed into a 
Simulink
®
 model and benchmarked using experimental data. This system was simplified 
after showing that production of induced 
109
Ag during irradiation of silver did not 
significantly affect elemental silver estimation by measurement of 
110m
Ag. Results from 
this model suggested that samples should be irradiated for up to 120 s and allowed to 
decay for 7 d before gamma ray spectroscopy is performed when investigating silver 
content in similar sodium-rich biological matrices via INAA in the future. 
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NOMENCLATURE 
 
AAS Atomic Absorption Standard 
AgNP Silver Nanoparticle 
CVP Texas A&M Cardiovascular Pathology Laboratory 
EDX Energy-dispersive X-ray Microanalysis 
FDA Food and Drug Administration 
HMDS Hexamethyldisilazane 
HPGe High-Purity Germanium 
INAA Instrumental Neutron Activation Analysis 
LM Light Microscopy 
LVAD Left Ventricular Assist Device 
NAA Neutron Activation Analysis 
NBF Neutral Buffered Formalin 
NSC Texas A&M Nuclear Science Center 
ODE Ordinary Differential Equation 
SDD Silicon Drift Detector 
SEM Scanning Electron Microscopy 
SNR Signal to Noise Ratio 
TEM Transmission Electron Microscopy 
THI Texas Heart Institute 
VAD Ventricular Assist Device 
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1. INTRODUCTION  
1.1 Objective 
The objective of this research is to determine the effectiveness of INAA as a 
means of quantifying silver concentration in biological matrices containing a silver 
nanoparticle-eluting biomedical device. This is of particular interest to applicable 
biomedical device manufacturers during preclinical trials for market approval. Thus, this 
research also aims to study how INAA correlates to other modalities more commonly 
used for pathology evaluations of implantable devices. Special consideration will be 
given to the context of manufacturers seeking the approval of the FDA. Another goal of 
this research is to develop a Matlab
®
/Simulink
®
 program to model the dynamics of the 
progeny produced by neutron activation of natural silver. 
1.2 Significance 
A major problem encountered with implantable biomedical devices is the 
prevalence of bacterial infection following their implantation [1]. For example, 
ventricular assist devices (VADs) currently approved for human use require 
percutaneous drivelines to deliver power and control to the intracorporeal pumps via an 
external battery worn on the patient’s hip. Drivelines are particularly susceptible to 
bacterial and fungal infections and biofilm formation, and they provide an access point 
for undesirable organisms to enter hosts [2]. These infections pose a major threat to the 
efficacy of VADs and reduce positive patient outcome [3-5]. Estimates suggest that up 
to 50% of left ventricular assist device (LVAD) patients develop infections related to 
their device [6]. According to the second annual INTERMACS report, the most common 
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cause of death in patients surviving at least one month on LVAD support is infection, 
resulting in 20.5% of deaths for over 1,000 patients [7]. In addition to decreasing 
treatment efficacy, high prevalence of driveline infection also increases the total 
financial burden of VAD therapy. Financial costs are estimated to double for patients 
that develop sepsis and increase more than sevenfold for patients that develop sepsis 
with pump housing infections and perioperative bleeding [8]. 
One way to combat infection is to coat or embed drivelines with various species 
of silver, which has well-documented antimicrobial properties [9, 10]. The exact 
mechanism of silver’s antimicrobial activity is unknown, but it is widely accepted that 
silver ions generate DNA-damaging reactive oxygen species and disrupt membrane 
protein function and membrane permeability [11]. AgNPs, silver chloride, silver salts, 
and silver composites have all been studied as chemical media for the release of silver 
ions to biological targets [11]. One study comparing the ability of multiple forms of 
silver to inhibit bacterial growth suggests that silver chloride colloid is superior to both 
AgNPs and silver ions in isolated Escherichia coli cultures [12]. In more complex 
biological systems, however, AgNPs offer the ability to control the extent of migration 
and elution throughout tissue based mainly on the size distribution of the nanoparticles 
[10]. Thus, AgNPs are currently utilized as a means to reduce biofilm formation and 
bacterial migration along percutaneous drivelines, but it is important that the coating 
remains local to the line to avoid toxic effects potentially suffered by the patient. 
Manufacturers must seek approval of the FDA prior to marketing biomedical 
devices in the United States. The FDA acts as a regulatory gauntlet, allowing biomedical 
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devices to progress to market only after demonstrating a certain degree of efficacy and 
safety. The FDA also aims to aid manufacturers in developing products to promote the 
treatment of disease and ailments in the US. One way they accomplish this is by 
publishing guidance documents for industry that detail their expectations. The guidance 
document for industry innovators seeking approval of medical devices that include 
antimicrobial agents (including antimicrobial AgNPs) is scheduled for release in 2014. 
Among other parameters, this document recommends manufacturers characterize the 
toxicity of the antimicrobial agent used, the release kinetics of the agent, and its 
minimum effective concentration [13]. While routine pathology investigations such as 
light microscopy (LM) and TEM provide invaluable information related to these 
parameters, they lack the ability to quantify the amount of a given substance within a 
sample. INAA has been successfully correlated to LM and TEM data to quantify 
colloidal gold in mice [14]. This research aims to determine whether INAA will provide 
similarly useful information when correlated to TEM for studies involving silver in 
biological matrices. These data could be submitted to the FDA along with pathology 
data for manufacturers seeking market approval of their silver-coated devices.  
1.3 Pathology Techniques 
 Many techniques are employed to investigate pathological changes to host tissues 
following biomedical device implantation. Pathologists at the Texas A&M 
Cardiovascular Pathology Laboratory (CVP) routinely interpret data from a variety of 
investigation modalities to determine how humans and animals respond to device 
applications at gross, cellular, and ultrastructural levels. The most commonly used 
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techniques for this are gross examination, LM, TEM, and SEM/EDX. Gross examination 
is useful to determine whether significant changes are present at a local tissue site or 
within single- or multiple-organ systems. Microscopic examination is warranted when 
gross changes are present or simply as a tool to enhance diagnoses, whether they are 
positive or negative. Fig. 1 compares which techniques are most useful to see structures 
of various sizes. Gross examination is suitable when researchers desire to see structures 
with a submillimeter resolution. To resolve features on submicron and nanometer scales, 
light and electron microscopy are used, respectively. 
 
 
Fig. 1 Resolving power of different modalities used for pathological investigations 
 
1.4 Electron Microscopy 
 Electron microscopy is performed when it is desirable to evaluate the 
ultrastructure of a specimen. TEM is utilized to view internal structures such as 
intracellular and extracellular components of biological specimens. Electrons are 
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accelerated through an ultrathin section of tissue and detected as they emerge from the 
sample, generating an image in which grayscale depends on electron density of the area 
viewed. Preparing samples for TEM requires the samples be biologically fixed, 
dehydrated, infiltrated with a solvent, polymerized, and sectioned into 80 – 120 nm thick 
slices. These slices are stained with heavy metal solutions to increase the electron 
density of different structures, causing the electrons to attenuate more strongly in some 
areas of the tissue. Uranyl acetate and Reynolds’ lead citrate are some commonly used 
metal stains in addition to osmium tetroxide, which also functions as a post-fixative for 
adipocytes and fatty tissue. The mechanisms behind the reactions of uranyl acetate and 
lead citrate with different tissues are poorly understood; however, these stains are noted 
to have an affinity for tissues post-fixed with osmium tetroxide prior to staining [15]. 
Lead citrate sometimes forms spherical precipitates within the tissues it stains that 
appear similar to AgNPs when viewed with TEM, as shown in Fig. 2 [16]. Thus, it is 
difficult to assess whether tissues contain AgNPs using TEM with no additional 
elemental discrimination since positive observations of highly attenuating spheres within 
biological samples may simply be caused by staining artifact. Some TEM systems are 
equipped with EDX systems, providing a means of reliable identification of elemental 
constituents within samples. Quantification of a measurand is also possible using this 
technique, but it requires detailed knowledge of sample geometry and a rigorous 
mathematical approach [17]. 
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Fig. 2 Comparison of similarities between a AgNP aggregate and lead citrate precipitates 
in TEM. Red arrows point to an intracellular aggregate of silver nanoparticles in pig skin 
(a) and lead citrate staining artifact in rat liver (b). Scale bars are 2 μm 
 
Quantifying nanoparticles with a TEM requires the distribution of nanoparticles 
and their aggregates to be spatially homogeneous on a scale comparable to the thickness 
of TEM sections. Fig. 3 illustrates some of the issues with analyzing TEM sections for 
nanoparticles when the size of the measurand is on the same scale as the section 
thickness. Section thickness is on the same order of nanoparticle size, making it difficult 
to accurately determine the amount of singular and aggregated nanoparticles within 
tissue based on TEM alone. For example, the uppermost aggregate (represented by an 
oval) intersects the sectioning line, and the entire cross-section of the aggregate is 
represented in Section A. Conversely, the true size of this aggregate would be 
underestimated if Section B were observed. 
 
a b 
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Fig. 3 Spatial heterogeneity of nanoparticle distribution between consecutive TEM 
sections 
 
 SEM is used to view surfaces of specimens that are either intact or that have been 
exposed by sectioning. Electrons are accelerated towards a bulk specimen and their 
backscatter or secondary electron distributions are used to generate an image of the 
surface. Backscatter detection is used to provide images in which grayscale is a function 
of elemental density (i.e., areas of low density appear to be dark compared to lighter 
areas representing high density). SEM preparation techniques are highly variable 
depending on the type of sample and laboratory capabilities. Techniques include 
biological fixation, dehydration, air or hexamethyldisilazane (HMDS) drying, 
desiccation, and mounting on carbon SEM stubs with double-sided tape. A low-vacuum 
chamber is sometimes used to scan surfaces of biological specimens to reduce sample 
charging and to avoid the need to coat the surfaces with conductive materials that could 
hinder elemental analysis and transferability to post-SEM histology. Elemental analysis 
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is possible when SEM systems include EDX hardware, and the ability to discriminate 
between most elements when viewing sample surfaces is useful. Standardless 
quantification, however, is fraught with error and highly affected by sample surface 
geometry, as shown in Fig. 4 [18]. An ideal geometry is shown (diagram a Fig. 4), where 
P is the total X-ray path length from within the electron interaction volume to the EDX 
silicon drift detector and S is the length of the X-ray path that may be affected by 
attenuation. For samples with surface ridges (diagram b Fig. 4), the S·P
-1
 ratio may 
increase, causing an underestimation of a measurand that is present within the interaction 
volume. For samples with surface valleys (diagram c Fig. 4), the S·P
-1
 ratio may 
decrease and measurand concentration will be overestimated.  
 
 
Fig. 4 Effects of sample surface geometry on EDX measurements for a flat surface (a), a 
ridge (b), and a valley (c) 
 
 Additionally, interaction volumes for electrons in silver vary significantly on the 
nanoscale. Adjusting electron beam potential in the SEM is necessary to achieve proper 
contrast at varying magnifications, but it may also greatly affect nanoparticle sampling 
a
a 
b c 
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volume and thus EDX results. Fig. 5 shows results from Monte Carlo simulations of 
electron interaction volumes in 100 nm diameter AgNPs performed using WinCasino 
(CASINO version 3, University de Sherbooke, Quebec, Canada). The 5 kV beam (image 
a Fig. 5) diverges significantly within the nanoparticle, and few electrons are shown 
escaping the bottom side of the nanoparticle. The 15 kV beam (image b Fig. 5) only 
slightly diverges as it travels through the nanoparticle, and most electrons are seen 
escaping its surface. 
 
 
Fig. 5 Comparison of Monte Carlo simulations of 5 kV (a) and 15 kV (b) electron beams 
interacting in a 100 nm diameter silver nanoparticle 
 
1.5 Neutron Activation Analysis 
 Neutron activation analysis (NAA) is an established method that can be used to 
quantify many elements to varying extents within bulk substrates or matrices [19]. 
Samples are subjected to a neutron field, and elements within the sample are activated 
and become radioactive. The resulting radionuclides that decay by emitting gamma rays 
a
a 
b
a 
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of known energies can be detected with a gamma ray spectrometer and used to quantify 
the amount of a measurand within the sample. NAA performed without chemical 
separation of measurands from irradiated samples is commonly referred to as INAA. 
Quantification of an element can be performed by the absolute method. Eq. 1 is used to 
calculate the amount of a measurand solely based on the counts observed under a 
specific photopeak with otherwise known data [20]: 
     
    
 
    
 
   
    
 [(       )        (       )     ]
  
, (1) 
where WSAM is the mass of silver in the sample; CSAM is the net counts under the i
th
 
photopeak in the sample; ε is absolute detector efficiency for the ith photopeak; I is the 
gamma ray intensity of the i
th
 photopeak; λ is the decay constant of the measurand; Ma is 
its atomic mass; mf is its isotopic abundance ratio; Na is Avogadro’s number; ta is 
activation time; td is decay time; tc is counting time; ϕ is neutron fluence rate; and σ is 
activation cross-section. 
 Neutron fluence rate and activation cross-sections are energy-dependent, but can 
be simplified into scalars or vectors representing effective values for a desired number of 
energy groups. Regardless, this method requires detailed knowledge of the neutron 
fluence rate distribution within a sample during activation and complete characterization 
of the inefficiencies of the spectrometer. Such information is not easily determined to a 
high degree of accuracy or is rarely available. If a standard with a similar matrix 
containing a known measurand concentration is irradiated under the same conditions as 
the sample of interest, the unknown mass of the measurand in the sample can be 
calculated using the comparator method: 
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, (2) 
where WSTD is the mass of silver in the standard; USAM is the propagated uncertainty of 
the calculated mass of silver in the sample; CSTD and σSTD are the net counts and 
uncertainty of the i
th
 photopeak in the standard; and σSAM is the uncertainty of the i
th
 
photopeak in the sample [20]. 
 Experiments performed to measure silver in various matrices are summarized in 
Table 1. Reactors are often utilized for high neutron fluence rates, irradiation times range 
from 3 s to 6 h, and counting times range from 30 s to 20 h. The most commonly 
monitored reactions are: 
      
         
   
          
→            
        , (3) 
      
         
   
           
→           
        , (4) 
      
         
    
          
→           
        . (5) 
 
Table 1 Summary of NAA experiment parameters found in the literature for biological 
and non-biological sample investigations 
Author, 
Reference 
Matrix 
Type 
Thermal Neutron 
Fluence Rate 
[n·cm
-2
·s
-1
] 
Decay(s) 
Monitored 
Irradiation  
Time [s] 
Counting 
Time [s] 
Adams [21] Metallic 1.00E+12 
110
Ag   < 30 < 900 
Albini [22] Particulate 3.50E+11 
110
Ag 120  < 160 
Sujari [23] Biologic 1.00E+12 
110m
Ag 21600 79200 
Randa [24] Biologic 8.00E+13 
110m
Ag < 18000 < 7200 
Gordus [25] Metallic 4.00E+04 
108
Ag, 
110
Ag 60 60 
Swain [26] Geologic 1.00E+13 
110m
Ag < 21600 n/a 
Pun [27] Geologic 2.30E+11 
110
Ag 10 30 
Pantelica [28] Biologic 3.00E+13 
110m
Ag 3600 < 72000 
Fukushima [29] Biologic 5.00E+11 
110
Ag 15 60 
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  The most commonly monitored gamma ray from activated biological samples 
containing silver is the 657 keV photopeak produced from the decay of 
110m
Ag  
(t0.5 = 250 d). An exception to this is shown in the experiment performed by Fukushima 
and Chatt [29]. These experimenters used Compton suppression during gamma 
spectroscopy to allow for rapid quantification of silver in oysters using the 657 keV 
photopeak produced by the much shorter-lived 
110
Ag (t0.5 = 24.6 s). Compton 
suppression is needed to perform rapid analysis with 
110
Ag due to the high sodium 
content in biological matrices. The sodium activation reaction is a major Compton 
continuum contributor for gamma ray spectroscopy of activated biological samples: 
      
        
  
           
→           
       . (6) 
If Compton suppression is not a possibility, the 
24
Na is usually allowed to decay 
significantly before counting is possible to a high degree of accuracy. 
The monitored reaction and the irradiation, decay, and counting times are chosen 
based on how sensitive the element in question is to neutron activation and how its half-
life compares to the half-lives of interfering radionuclides produced in the sample as 
byproducts. For this experiment, 
110m
Ag is chosen as the silver isotope to monitor due to 
its long half-life compared to the 
24
Na byproduct that is expected to be abundant in the 
sample after irradiation. Na-24 activity reduces to approximately 0.1% of its original 
value 150 h (ten 
24
Na half-lives) after irradiation; however, 
110m
Ag will only reduce to 
approximately 98% of its original activity in the same time. Additionally, in the context 
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of a device manufacturer performing this analysis as a means to evaluate a product 
during a preclinical trial, it is desirable to keep service cost low and sample throughput 
high. Thus, irradiation time is kept to a minimum while post-irradiation and pre-counting 
decay times can be extended to allow for adequate 
24
Na decay. 
Natural silver consists of 51.84% 
107
Ag and 48.16% 
109
Ag, and both of these 
isotopes have significant neutron capture cross-sections as shown in Fig. 6. The cross-
sections for 
107
Ag and 
109
Ag are similar for the majority of the resonance region; 
however, 
109
Ag has a large resonance capture peak at 5.2 eV that 
107
Ag does not. The 
thermal cross-section for 
107
Ag is also lower than for 
109
Ag. It should be noted that the 
cross-sections for 
110m
Ag are comparable to those for 
107
Ag and 
109
Ag throughout the 
thermal and resonance energy ranges with exception of the 5.2 eV 
109
Ag resonance. 
 
 
Fig. 6 Radiative capture neutron cross-sections for 
107
Ag, 
109
Ag, and 
110m
Ag. Data was 
accessed from the ENDF/B-VII.2 database via Janis [30] 
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 When a sample containing natural silver is introduced to a neutron field, 
108
Ag 
and 
110
Ag and their metastable states build up within the sample. These nuclides undergo 
radioactive decay to produce isotopes of cadmium and palladium, or they may double-
capture to form 
109
Ag and 
111
Ag, respectively. Thus, the activation of silver produces a 
complex web of activation and decay products as shown in the diagram in Fig. 7.  
 
 
Fig. 7 Activation (solid green arrows) and decay (dotted red arrows) products resulting 
from the exposure of natural silver to a neutron field. Natural abundances are listed for 
107
Ag and 
109
Ag. Also listed are decay modes and half-lives for the radionuclides and 
their metastable states [31]. A legend is shown in the upper-left box labeled “Nuclide” 
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 Pathways of most interest in Fig. 7 are those that contribute to the buildup of 
induced 
109
Ag, such as those shown in Eqs. 7 – 9: 
    
   
          
→         
          
→           
   
  
   , (7) 
    
   
          
→         
          
→         
        
→          
   
  
    
  
   , (8) 
    
   
          
→         
        
→        
          
→         
   
  
     
        
→        
       
   . (9) 
Induced production of 
109
Ag may cause false positive interference with the amount of 
110m
Ag measured during gamma ray spectroscopy. If all 
109
Ag is assumed to be natural 
and this induced production of 
109
Ag is indeed significant, using the absolute method of 
INAA to measure silver may lead to overestimates of the concentrations reported after 
analysis. Another source of error may arise if 
110m
Ag is produced from triple activation 
of 
107
Ag as in the pathway described in Eq. 10: 
    
   
          
→         
          
→         
          
→           
    
  
    
  
   . (10) 
This may introduce false positive observation of silver if all measured 
110m
Ag is assumed 
to be produced from 
109
Ag. It should be noted that the interference processes described 
in Eqs. 7 – 10 are hypothesized to be more relevant for analyses performed with higher 
neutron fluence rates and longer irradiation times. 
 A system of coupled ODEs can be constructed from this diagram by considering 
each nuclide box to be a compartment that can either be “filled” or “emptied” by each 
activation or radioactive decay process that occurs. Solving this system results in the 
time-dependent inventory of each nuclide and their metastable states that may be 
produced when silver is neutron activated. This system is shown in Eqs. 11 – 24: 
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where N is the number of atoms of a certain nuclide; m0 is initial mass of an element; Fg 
is the fraction of activations resulting in a ground state; Fm is the fraction of activations 
resulting in a metastable state; and Yε, Yβ, and YIT are branching ratios for electron 
capture, beta decay, and internal transition processes; respectively. In the case that 
interference from these progeny and induced buildup of 
109
Ag can be ignored, this 
system simplifies to the following: 
(
  
  
)
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)
     
  (  )     , (25) 
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)
      
 (    )
      (  )        (  )      , (26) 
which assumes that contribution to 
110m
Ag inventory by induced 
109
Ag is negligible and 
that only naturally-occurring 
109
Ag contributes to the production of 
110m
Ag. Loss of 
110m
Ag to activation is still considered in the simple model due to its comparably large 
cross-section shown in Fig. 6. 
 Sodium activation kinetics are more straightforward and can be represented by: 
(
  
  
)
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)
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    , (27) 
(
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2. MATERIALS AND METHODS  
This research was performed in three stages. First, a feasibility trial was 
performed with positive control samples to establish a qualitative standard for how silver 
nanoparticles appeared grossly and microscopically and study whether INAA could 
provide the necessary quantitative information. Second, an experimental trial was 
performed in which samples from two silver-coated driveline implant sites were studied 
for the amount of silver present using experience from the feasibility trial. Finally, a 
mathematical model was constructed to simulate the behavior of silver and its activation 
and decay products in a neutron field similar to that provided in the small sample 
irradiation port at the Texas A&M Nuclear Science Center (NSC). 
2.1 Feasibility Trial 
A sample of porcine skin was injected post-explant with a proprietary AgNP 
solution of unknown concentration and fixed in 10% neutral buffered formalin (NBF). 
NBF is an aqueous solution containing formaldehyde, methanol, and a sodium phosphate 
buffer (Cardinal Health Inc., Dublin, OH). Once fixed, the skin was delivered to CVP 
and gross photographs were taken of the sample before it was dissected into sections for 
TEM, INAA, and SEM/EDX as shown in Fig. 8. These samples were placed in Cassettes 
1, 3, and 5, respectively, and submitted for processing for each modality. Fig. 8 also 
shows photographs of these sectioned samples.  
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Fig. 8 Overview of the whole specimen and the samples taken for analysis. The whole 
specimen (a) was sectioned into pieces for TEM (b), INAA (c), and SEM/EDX (d). 
Ruler tick marks in photographs (b,c,d) are in millimeters 
 
Cassette 1 was immersed in Trump’s fixative and shipped to the Texas Heart 
Institute (THI) for TEM processing. Trump’s fixative is an aqueous, sodium phosphate 
buffered solution containing a 4:1 ratio of formaldehyde to glutaraldehye [32]. The 
sample was post-fixed in osmium tetroxide and dehydrated in a series of aqueous 
solutions with increasing ethanol concentrations. It was embedded in a Poly/Bed 812 
(Polysciences, Inc., Warrington, PA) plastic resin block before 80 nm sections were cut 
and mounted on 100 mesh copper grids. These sections were stained with uranyl acetate 
and lead citrate. Images were taken with a JEM 1250 (JEOL USA, Inc., Peabody, MA) 
a b 
c d 
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electron microscope and delivered to CVP for observation of ultrastructural 
characteristics of the samples by a pathologist. 
Cassette 3 was delivered to the NSC in formalin for INAA preparation. The 
sample was removed from formalin, weighed, and double-sealed within two 
polyethylene vials. Similarly, two double-sealed polyethylene vial samples were filled 
with 1 µL each silver nitrate-based atomic absorption standard (AAS) containing 
987 ppm silver (Sigma Aldrich Corp., St. Louis, MO). All three vials were successively 
irradiated for 60 s in the D2 sample irradiation port of the NSC TRIGA Mark I reactor 
while it operated at 1 MW power. Samples were allowed to decay for 1 d before 
acquiring gamma ray spectra for 600 s of live time each in a high-purity germanium 
(HPGe) detector equipped with a multi-channel analyzer and a computer with GENIE™ 
2000 software (detector and software from Canberra Industries Inc., Meriden, CT). 
Gamma ray spectra were analyzed in GENIE™ by 2nd differential peak location and 
non-linear least-squares fitting peak area calculation algorithms. Gamma ray peak 
identification was automated in GENIE™ using the standard nuclide identification 
library and unidentified peaks were further analyzed manually. The detector was 
previously calibrated for energy and efficiency with 
152
Eu and 
60
Co sources, 
respectively, by NSC personnel. When the 657 or 884 keV peaks were observed, the 
amount of silver in the tissue sample was calculated using Eq. 2. 
 The tissue from Cassette 5 was submitted for SEM/EDX and dehydrated in a 
series of aqueous solutions with increasing ethanol concentrations. The sample was 
allowed to dry in air until surfaces no longer glistened, then subjected to vacuum 
 21 
 
desiccation for further drying. Once dry, the sample was mounted on a carbon stub with 
double-sided conductive carbon tape and analyzed in a TM-3000 Tabletop SEM (Hitachi 
High Technologies America, Inc., Dallas, TX) equipped with an XFlash
®
 silicon drift 
detector (SDD) and Quantax
®
 EDX analysis software (detector and software from 
Bruker Biosciences Corp., Billerica, MA). SEM images and EDX spectra were acquired 
with 5 and 15 keV electron beams on both low- and high-current modes as deemed fit 
for each sample. EDX detector live time ranged from 128 – 158 s for all spectra 
acquired. X-ray peak identification and elemental mapping was automated in Quantax
®
; 
in addition, unidentified peaks were analyzed manually. The SDD was previously 
calibrated for energy using a copper calibration control. 
2.2 Experimental Trial 
 Two driveline segments were explanted from a porcine model 43 d post-implant 
at a remote facility as part of a preclinical study conducted by an industry investigator. 
Each driveline was wrapped in velour that served as the interface between the device and 
the host’s skin. One driveline’s velour was coated in a AgNP solution that was known to 
leech into surrounding tissue (control article; Site 5). The other driveline was coated in a 
AgNP solution that was hypothesized to stay local to the device and not leech into 
surrounding tissue (test article; Site 3). Upon explant, each site consisted of a driveline 
embedded in approximately 55 cm
3
 of porcine skin, or plugs. These plugs were fixed in 
10% NBF before delivery to CVP. Gross photographs and radiographs were taken of the 
plugs before they were dissected into sections for TEM, INAA, and SEM/EDX as shown 
in Fig. 9. These samples were placed in labelled cassettes and submitted for processing 
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for each analysis modality. Cassettes taken from Site 3 and Site 5 are shown in 
Appendix A. Sectioned strips of tissue are labeled with numbers (black) in the locations 
from which corresponding cassettes were collected. Cassettes are labeled (yellow) with 
the modality for which each was prepared. Unlabeled cassettes were not processed. 
 
 
Fig. 9 Comparison of gross and radiographic appearances of the test article 
 
Cassettes 2 and 11 were immersed in Trump’s fixative and shipped to THI for 
TEM processing. The same protocol was used to process and analyze these samples as 
was used in the feasibility trial. 
Cassettes 3, 6, 9, 12, 15, 18 were immersed in Trump’s for further fixation. Prior 
to INAA processing, the fixative within the samples was replaced with 70% aqueous 
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ethanol in an attempt to decrease the amount of sodium present within the samples 
during irradiation. Achieving a decrease in sodium content at the time of gamma ray 
acquisition was desired to reduce the background behind the measurand peaks and 
reduce gamma radiation exposure to NSC staff during sample handling. Samples were 
delivered to the NSC, removed from 70% ethanol, weighed, and double-sealed in 
polyethylene vials along with two 1 µL samples of the 987 ppm silver nitrate AAS. All 
vials were successively irradiated for 40 s each in the D2 sample irradiation port of the 
NCS TRIGA Mark I reactor with the reactor operating at 1 MW power. Samples were 
allowed to decay for approximately 6 d before acquiring gamma ray spectra for 600 s of 
live time each in a HPGe detector equipped with a multi-channel analyzer and a 
computer with GENIE™ 2000 software. The detector was previously calibrated for 
energy and efficiency by NSC personnel with 
152
Eu and 
60
Co sources, respectively. 
Other than the aforementioned changes in the fixation protocol and irradiation and decay 
times, the remainder of the analysis performed was the same as the feasibility trial.  
Cassettes 1, 4, 7, 10, 13, 16 were submitted for SEM/EDX and dehydrated in a 
series of aqueous solutions with increasing ethanol concentrations. An absolute ethanol 
wash was followed with HMDS drying before the samples were allowed to air dry in an 
attempt to reduce drying artifact. After HMDS and air drying, all samples were 
desiccated in vacuum. Cassettes 1, 4, and 7 were mounted on a single large SEM stub 
with double-sided carbon tape; Cassettes 10, 13, and 16 were prepared similarly. The 
TM-3000 SEM was used to analyze all samples the same way the samples were 
analyzed in the feasibility trial with EDX acquisition live times ranging between 
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11 – 520 s for all spectra obtained. X-ray peak identification and elemental mapping was 
automated in Quantax
®
; in addition, unidentified peaks were analyzed manually. The 
SDD was previously calibrated for energy using a copper calibration control. 
2.3 Simulation 
 A compartmental model was constructed in Matlab
®
/Simulink
®
 (Version 
R2011a, MathWorks, Inc., Natick, MA) to calculate the inventory of each concerned 
radionuclide produced during neutron activation of silver and sodium and the progeny 
produced by subsequent radioactive decay. The model contained modules to initialize 
sample and activation parameters including neutron fluence rate, amount of elemental 
silver and sodium prior to irradiation, irradiation time, decay time, and counting time. 
These input modules are shown in Fig. 10 and Fig. 11. In Fig. 10, the “Switch” block 
changed the fluence rate to zero when the time on the simulation clock reached a value 
specified by the user, ending irradiation. The “Goto” block allowed wireless 
communication between this module and the rest of the model. Initial silver amount was 
specified in milligrams and converted to atoms, then communicated to the ODE modules 
with the “Goto7” block. In Fig. 11, the “Integrator5” block accumulated decays 
undergone by 
110m
Ag once the time specified by the user in the “Switch1” block reached 
a certain value. The “Ag10m detected” functions multiplied these decays by branching 
ratios and detector efficiencies associated with the 657 and 884 keV peaks from 
110m
Ag. 
The “…Counts” scopes displayed the total number of counts registered by the simulated 
detector for each energy channel. 
 
 25 
 
 
Fig. 10 The fluence rate controller and elemental silver initiation modules 
 
 
Fig. 11 The detector simulator 
 
The model also contained modules for each compartment, or isotope, that 
accepted “wireless” inputs and output the inventory at each time step calculated. 
Examples of this are shown in Fig. 12 and Fig. 13. In Fig. 12, the “From34”, “From30”, 
and “From29” blocks transferred contributions to 110Ag inventory from other activation 
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and decay processes accounted for elsewhere in the model after branching ratios and 
metastable yields were calculated. The “Ag10A (cm2)” block accounted for loss from 
neutron activation when multiplied by the fluence rate value communicated via 
“From28” block, and “Ag10D (/s)” accounted for radioactive decay. “Add9” 
accumulated changes to the inventory from all processes during each iteration. Inventory 
was displayed in atoms as well as with a scope. A scope output is shown in Fig. 13. To 
generate this plot, the complex simulation was performed with an activation time of 60 s 
and total time of 300 s, then the “Ag10 (atoms)” block from Fig. 12 was viewed. 110Ag 
inventory peaked at 60 s, and 240 s after irradiation (approximately ten 
110
Ag half-lives) 
the inventory was nearly depleted. 
 
 
Fig. 12 The module used to calculate 
110
Ag activity 
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Fig. 13 Example of Simulink
®
 scope output. Time is shown in seconds on the abscissa 
and 
110
Ag inventory is in atoms on the ordinate 
 
The complex model is shown in its entirety in Appendix B, and the simple model 
is shown in Appendix C. The complex version of the model was used to solve the 
coupled ODEs in Eqs. 11 – 24 with the ODE45 4th order Runge-Kutta solver native to 
Matlab
®.
 Automatically optimized variable time steps and a relative error tolerance of 
10
-3
 were used.  A simplified version of the model was used to solve Eqs. 25 and 26 
using the same parameters. Both models were used to solve Eqs. 27 and 28 to simulate 
sodium activation. Results from the feasibility and experimental trials were used to 
benchmark the computational models and determine which fluence rate scheme 
produced the best results. Results from the complex and simple systems were compared 
to determine the extent of error introduced by the assumptions made for the simple 
model. 
Radiative neutron capture cross-sections and metastable isomer yield ratios were 
obtained from the TENDL-2013 library via Janis [33]. An exception was the data for the 
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109Ag(n,γ)110mAg reaction, which was experimentally determined by Nakamura, et. al. 
[34]. Only thermal (10
-5
 < E < 0.5 eV) and resonance (0.5 < E < 10
5
 eV) cross-sections 
were found to be significant, and fast activation processes were neglected. Thus, a two-
group fluence rate scheme was utilized as a compromise between computational ease 
and accuracy. 
Tested fluence rate values were based on the measurement and simulation results 
reported by Parham [35]. Parham measured thermal and epithermal fluence rates of 
7.50×10
12
 and 2.40×10
11 
n·cm
-2
·s
-1
, respectively, in the small sample irradiation port D2 
at the NSC reactor. MCNP simulations determined thermal and epithermal fluence rates 
to be 1.02×10
13
 and 2.37×10
11 
n·cm
-2
·s
-1
, respectively. Since cross-section values were 
obtained as resonance integrals, epithermal fluence rate was converted to resonance 
fluence rate for one of the tested schemes using Eq. 29 and the assumption that the 
resonance fluence rate distribution in the NSC core follows the E
-1
 assumption for light 
water reactors [36]. 
     ∫  ( )
      
      
        
   
   
             
    
    
, (29) 
where ϕepi is epithermal fluence rate; ϕres is the resonance fluence rate; φ(E) is the 
fluence rate distribution; and Elower and Eupper are the energy bounds of the resonance 
region. The simulation was solved with various fluence rate schemes until the most 
agreeable results were obtained. 
 The degree of difference between experimental and simulated results was 
determined by calculating ratios of the difference of experimentally determined net peak 
area to simulated net peak area as shown in Eq. 30: 
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where R
i
 is the degree of difference for the i
th
 photopeak and Aexp and Asim are the net 
peak areas for experimental and simulated results of the i
th
 photopeak, respectively. Net 
peak areas for the 
110m
Ag photopeaks at 657 and 884 keV were both used for this 
determination. This metric was used as a benchmark for the compartmental model. 
 Eq. 31 was used to compare results predicted by the simple and complex models: 
  (
|         |
    
)
       
, (31) 
where   is the degree of difference between the models and Nspl and Ncpx are the 
simulated 
110m
Ag inventories at 7 d following the beginning of irradiation for the simple 
and complex models, respectively. The simulation was run for 7 d of total time, and 
irradiation time was varied from 10 to 1000 s. The degree of difference between the 
complex and simple models was calculated using Eq. 31 and plotted as a function of the 
fraction of total analysis time spent in irradiation. The model was used to support 
suggestions for modifications to potential future experiments by simulating and 
comparing 
110m
Ag inventories for various suggested timing schemes. 
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3. RESULTS AND DISCUSSION  
Results from the three stages of research are presented here. Images and INAA 
analysis results are reported for the feasibility and experimental trials. The 
computational model benchmarking and analysis results are presented as well. 
3.1 Feasibility Trial 
 Representative transmission electron micrographs of the AgNP-injected pig skin 
taken in Cassette 1 are shown in Fig. 14. Intracellular (micrographs a, b Fig. 14) and 
extracellular (micrograph c Fig. 14) AgNPs were visible. High magnification 
(micrograph d Fig. 14) also showed individual AgNPs within an aggregate. Tissue 
reaction to AgNPs was not observed due to the injection occurring post-mortem; all 
observed AgNP behavior and localization was strictly due to diffusion and chemical 
processes. Suspected AgNPs ranged from small and singular to large and clustered. 
These images suggested that AgNPs were difficult to distinguish from surrounding 
metal-stained morphology at low magnifications unless they were clustered together to 
form larger, dense aggregates. Aggregation affinity also appeared to be nonspecific to 
location within or outside of cellular compartments. These images simply served as a 
control to familiarize the experimenters with AgNP appearance. In addition, they 
enabled a better understanding of how ultrastructural localization of AgNPs may be 
affected by pathological processes in the experimental trial. 
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Fig. 14 The appearance of AgNP in TEM images is standardized in this figure. Scale 
bars are 500 nm (a,c), 2 µm (b), and 100 nm (d) 
 
 Cassette 3 was subjected to NAA; results from automated spectrum analysis in 
GENIE™ are shown in Table 2. The mass of silver in each standard was calculated 
using the 987 ppm silver concentration reported in the documentation of the standards. 
The amount of silver in the sample in Cassette 3 was calculated using both 657 and 
a b 
c d 
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884 keV peak data with each standard and Eq. 2. Results of these calculations are shown 
in Table 3. 
 
Table 2 Peak analysis results from GENIE™ for the two standards and section of tissue 
subjected to INAA during the feasibility trial 
Sample 
Descriptor 
Total Sample 
Mass [g] Silver Mass [µg] 
657 keV Peak 
Area [counts] 
884 keV Peak 
Area [counts] 
Standard A 0.2052 202.5 758 ± 30.50 511 ± 23.57 
Standard B 0.1990 196.4 756 ± 30.33 476 ± 24.13 
Cassette 3 0.2996 N/A 7890 ± 147.84 4760 ± 140.05 
 
Table 3 The amount of silver present in the feasibility skin sample 
 Standard A Standard B 
657 keV Peak 2108 ± 93.57 µg 2050 ± 90.77 µg 
884 keV Peak 1887 ± 103.22 µg 1964 ± 115.12 µg 
 
A noticeable feature of the values reported in Table 3 is that using the 884 keV 
peak to quantify silver resulted in lower amounts than using the 657 keV peak. 
Furthermore, the error associated with the 884 keV peak calculations was higher for both 
standards. Fig 15 shows a comparison of the gamma ray spectra obtained from counting 
Standard A (spectrum a Fig 15) and Cassette 3 (spectrum b Fig 15). In contrast to the 
spectrum from Standard A, The spectrum from the sample in Cassette 3 displayed a 
background dominated by the 1386 and 2754 keV peaks emitted by 
24
Na from within the 
sample. The Compton continuum from these peaks had a significant presence that was 
thought to mask the 657 and 884 keV 
110m
Ag peaks used in this analysis. Since the  
884 keV peak had a lower intensity, its signal did not stand out as well from the 
background caused by 
24
Na. A signal-to-noise ratio (SNR) was computed using the 
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GENIE™ output of net area and continuum counts for each peak; these values are shown 
in Table 4. Correlating results shown in Fig 15 and Table 4, it was concluded that 
24
Na 
was the major source of background causing poor SNR and therefore, the strong 
presence of 
24
Na in the skin samples significantly contributed to silver measurement 
error. 
 
 
Fig 15. Feasibility trial gamma ray spectroscopy output provided by GENIE™. The 
gamma ray spectrum from Standard A (a) is compared to the spectrum acquired from 
Cassette 3 (b). Abscissae are energy and ordinates are net counts. The 
110m
Ag and 
24
Na 
peaks used in the analysis are noted by blue and white arrows, respectively 
 
110m
Ag 
24
Na 
a 
b 
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Table 4 The SNR for each measured silver peak and each sample from the feasibility 
trial 
 Standard A Standard B Cassette 3 
657 keV Peak 13.7 12.9 1.8 
884 keV Peak 37.6 14.0 1.0 
 
 SEM with EDX was performed on the sample in Cassette 5; representative 
images from this analysis are shown in Fig. 16. A localized region of high contrast was 
noted from a low magnification (micrograph a Fig. 16) and was determined to be silver 
using EDX (elemental overlay b Fig. 16). High magnification of the surface showed 
randomly dispersed areas of high contrast varying in size (micrograph c Fig. 16) which 
were also shown to be silver using EDX (elemental overlay d Fig. 16). In this case, SEM 
itself did not provide detail that could not be obtained with TEM. Regardless, EDX 
results illustrated the power of elemental mapping overlays with grayscale images. Areas 
of high contrast were shown to be silver against a background composed predominately 
of carbon and oxygen. EDX was also able to eliminate other areas of high contrast by 
determining they were caused by surface charging or contamination from the sample 
preparation room. Due to the geometry and beam sampling limitations discussed 
previously, quantitative elemental analysis was not attempted. 
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Fig. 16 SEM images and EDX maps from the surface of the sample in Cassette 5. Scale 
bars are 2 mm (a) and 500 µm (b) 
 
3.2 Experimental Trial 
 Representative TEM images of Cassettes 2 and 11 containing the pig skin 
collected from sites adjacent to control and test article sites are shown in Fig. 17. The 
control article showed at low magnification (micrograph a Fig. 17) notable amounts of 
intracellular (asterisks) and extracellular (arrows) AgNP aggregates. A higher 
magnification (micrograph b Fig. 17) showed accumulations of AgNPs within a 
phagocytic cell (asterisks) and within a collagen matrix (arrows). The test article showed 
at low magnification (micrograph c Fig. 17) an admixture of inflammatory cells 
including macrophages (m), neutrophils (n), lymphocytes (l), and phagocytes (p); 
however, AgNPs were not noted. Higher magnification (micrograph d Fig. 17) showed 
a b 
c d 
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an aggregate of AgNPs (asterisk) and scattered singular AgNPs throughout an acellular, 
serous substrate at the tissue-device interface. Many of the aggregates were noted within 
phagocytic cells, while smaller collections of AgNPs were typically noted in interstitial 
spaces or within the connective tissue deposited in response to the device’s presence. 
AgNP aggregates were much less prominent in the test site. Some singular AgNPs were 
noted in interstitial spaces. 
 
Fig. 17 Representative TEM findings for test and control samples in the experimental 
trial. Scale bars are 2 µm (a,c) and 500 nm (b,d) 
p 
n 
m 
l 
a 
c d 
b 
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 Cassettes 3, 6, 9, 12, 15, and 18 were subjected to INAA; results from automated 
spectrum analysis using GENIE™ are shown in Table 5. The mass of silver in each 
standard was calculated using the 987 ppm silver concentration reported in their 
documentation. The amount of silver from the control sample in Cassette 12 was 
calculated using both 657 and 884 keV peaks with each standard and Eq. 2. Results of 
these calculations along with the SNR for each peak are shown in Table 6. 
 
Table 5 Peak analysis results using GENIE™ for the standard and sections of tissue 
subjected to INAA during the experimental trial. Data for cassettes taken from tissue 
adjacent to the control article are highlighted 
Sample 
Descriptor 
Total Sample 
Mass [g] 
Silver Mass 
[µg] 
657 keV Peak 
Area [counts] 
884 keV Peak 
Area [counts] 
Standard 0.2520 248.7 684 ± 28.57 373 ± 21.38 
Cassette 3 0.3034 N/A N/A N/A 
Cassette 6 0.2210 N/A N/A N/A 
Cassette 9 0.3102 N/A N/A N/A 
Cassette 12 0.2799 N/A 56.7 ± 16.51 28.0 ± 14.52 
Cassette 15 0.2304 N/A N/A N/A 
Cassette 18 0.3438 N/A N/A N/A 
 
Table 6 The amount of silver present in Cassette 12 from the experimental samples. 
SNR for each peak is also included 
 Cassette 12 SNR 
657 keV Peak 20.62 ± 6.07 µg 0.7 
884 keV Peak 18.67 ± 9.74 µg 0.4 
 
Silver was only detectable in the sample taken from the site most adjacent to the 
control sample, Cassette 12. Silver content was determined to be 18.67 µg within the  
280 mg sample, or approximately 67 ppm, based on the 884 keV peak, but this 
determination had a 52% error. Using the 657 keV peak resulted in a silver amount of 
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20.62 µg within the 280 mg sample, or approximately 74 ppm, with a smaller error of 
29%. The SNR for the 657 keV peak was also nearly double that of the 884 keV peak; 
however, SNRs were consistently lower than those observed during the feasibility trial. 
Background noise was greatly reduced by replacing the sodium phosphate buffered 
fixative solution in the samples with ethanol prior to irradiation and allowing the 
activated sodium longer to decay between the end of irradiation and start of gamma ray 
acquisition. Signal was reduced to a greater extent, however, due to the much lower 
content of silver in the experimental sample and the shorter irradiation time. These 
observations are supported by the comparison of gamma ray spectra shown in Fig. 18. 
The most prominent feature noted for Cassette 3 (spectrum b Fig. 18) is the Compton 
continuum caused by the strong presence of 
24
Na. Contrarily, 
24
Na is not as prominently 
present for Cassette 12 (spectrum a Fig. 18). 
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Fig. 18 Gamma ray spectra from Cassette 12 in the experimental trial (top) and Cassette 
3 in the feasibility trial (bottom). Abscissae are energy and ordinates are net counts. The 
110m
Ag and 
24
Na peaks used in the analysis are noted by blue and white arrows, 
respectively 
 
SEM with EDX showed little difference between the surfaces of samples taken 
from adjacent to the control and test articles. Representative images of this analysis are 
shown in Fig. 19. A single area of high contrast was found on the control sample from 
Cassette 10. The high contrast area consisted of an aggregation of granular particles 
embedded within the tissue (micrograph c red circle Fig. 19) that emitted a strong 
characteristic silver X-ray signal when analyzed with EDX (spectrum d Fig. 19). The 
area measured approximately 10 µm in greatest dimension, however, and was not 
representative of the entire area analyzed. EDX was able to eliminate other areas of high 
contrast by determining the cause was surface charging or contamination from the 
sample preparation room. 
110m
Ag 
24
Na 
a 
b 
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Fig. 19 Representative SEM images from the control (a) and test (b) articles. An area of 
the control article (c, red circle) was analyzed with EDX. Scale bars are 2 mm (a,b) and 
30 µm 
 
3.3 Simulation 
 Three fluence rate schemes were tested with the model. The areas predicted by 
the model for the 657 keV peak were compared to net peak areas measured for various 
activation and decay times used in the feasibility and experimental trials. Eq. 30 was 
used to calculate the degree of agreement between experimental and simulation results 
as shown in Table 7. The measured, simulated, and resonance-corrected fluence schemes 
predicted 657 keV peak areas with average errors of 15.0 ± 15.3%, 24.5 ± 27.8%, and  
19.0 ± 6.9%, respectively. While the degree of difference between predicted and 
a 
c d 
b 
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measured values had a lower average error using the measured fluence scheme, the 
resonance-corrected fluence scheme was chosen for the remainder of the simulations due 
to the much lower standard deviation of errors in the predictions. This scheme 
considered fluence rate as two-group with thermal and resonance components of 
1.02×10
13
 and 1.97E×10
10
 n·cm
-2
·s
-1
, respectively. 
 
Table 7 Fluence rate schemes tested during model benchmarking and the calculated 
agreement metric values. The average and standard deviation of all the metrics for the 
resonance-corrected fluence rate scheme are highlighted 
 Measured Simulated Resonance-Corrected 
 Thermal Epithermal Thermal Epithermal Thermal Resonance 
[n·cm
-2
·s
-1
] 7.50E+12 2.40E+11 1.02E+13 2.37E+11 1.02E+13 1.97E+10 
       
Sample 
Descriptor 
657 keV 
Peak 
884 keV 
Peak 
657 keV 
Peak 
884 keV 
Peak 
657 keV 
Peak 
884 keV 
Peak 
Standard A 0.066 0.178 0.148 0.011 0.150 0.252 
Standard B 0.092 0.144 0.116 0.052 0.173 0.221 
Skin 0.407 0.384 0.729 0.701 0.280 0.260 
Standard 0.164 0.091 0.027 0.117 0.239 0.172 
Cassette 12 0.020 0.177 0.204 0.446 0.108 0.071 
Average 0.150 0.195 0.245 0.265 0.190 0.195 
Std. Dev. 0.153 0.112 0.278 0.298 0.069 0.077 
 
Once the appropriate fluence rates were determined, the complex and simple 
models were compared by using them to predict 
110m
Ag inventories at 7 d following the 
beginning of irradiation and applying Eq. 31. Results of this analysis are shown in 
Fig. 20. The degree of difference between the models increased linearly with a perfect 
correlation as the fraction of analysis time spent irradiating the samples increased. Thus, 
the simple model was believed to become less accurate if used to simulate samples with 
longer irradiation times and shorter decay times. According to the trend line equation in 
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Fig. 20, the maximum amount of theoretical error in predicted 
110m
Ag inventory that may 
have been introduced by assuming the simple model was approximately 0.05%. This 
was thought to be negligible in comparison to the error of 20% associated with the 
fluence rate values chosen for the model. Therefore, the simple model was thought to 
predict 
110m
Ag activity just as well as the complex model for the purposes of this 
research. 
 
  
Fig. 20 Comparison of how the complex and simple models differ in predicting 
110m
Ag 
inventory for various activation schemes. The dotted line shows the linear relationship 
described by the trend line equation. Data points were calculated using Eq. 31 and are 
shown as red “X” markers 
 
 The simple model was used to calculate 
110m
Ag and 
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approximate activation schemes used in the feasibility and experimental trials. The 
results were compared to schemes thought to be advantageous for future work. Fifty 
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micrograms of silver and 100 and 200 µg of sodium were input to the model. TEOI was 
the irradiation time, and TTotal was the total amount of time that the sample was 
irradiated, allowed to decay, and counted for 600 s. Results are shown in Table 8. A 
graphical summary of results is shown in Fig. 21. 
 
Table 8 Simulated peak areas for 
110m
Ag and 
24
Na for various irradiation times. 
Parameters used for the feasibility and experimental trials are highlighted in gray 
  Simulated Peak Area [counts] 
TEOI [s] TTotal 657 keV  884 keV 1368 keV 2753 keV 
60 18 hours 160 95 35455 19515 
40 6 days 105 62 71 39 
60 6 days 157 93 106 59 
60 7 days 157 93 35 19 
120 7 days 313 186 70 39 
 
 
Fig. 21 Simulated peak areas for the 657 keV 
110m
Ag and 1368 keV 
24
Na peaks for 
various irradiation schemes. The feasibility trial simulation is not included 
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 Assuming the ability to quantify silver depended mainly on SNR for the 657 keV 
peak, and the noise under the peak was primarily caused by the Compton continuum 
from the 1368 keV 
24
Na peak, Table 8 and Fig. 21 show that decay time was the primary 
factor governing the ability to quantify silver in these types of biological matrices. In the 
experimental trial TEOI was 40 s and the samples were allowed to decay for 
approximately 6 d. The simulation showed that increasing irradiation time to 60 s made 
the samples more radioactive, but the difference between the intensities of the 657 and 
1368 keV peaks did not change by much. Allowing the samples to decay for 7 d after 
60 s of irradiation, however, greatly decreased 
24
Na activity. Thus, increasing decay time 
from 6 to 7 d would greatly increase the ability to quantify silver in these types of 
samples. Doubling irradiation time to 120 s prior to allowing approximately 7 d of decay 
increased the areas under each peak as expected, but also increased the ratio between the 
intensity of the two. Fig. 22 was generated using output from the simulation and shows 
the relationship between the 657 and 1368 keV gamma rays detected from 
110m
Ag and 
24
Na at various times following 120 s of irradiation of 50 µg of silver and 100 and 
200 µg of sodium. These data could be used to predict ratios of silver and sodium peak 
areas for various irradiation timing schemes for improved design of future experiments. 
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Fig. 22 Comparison of detectable gamma ray ratios from 
110m
Ag and 
24
Na following 
irradiation of 50 µg of silver with 100 or 200 µg of sodium 
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4. CONCLUSIONS  
 
TEM analysis of AgNP-containing skin samples yielded qualitative results of 
host reaction to AgNPs. In the experimental trial, inflammatory cells exhibited an 
expected reaction to the presence of a device at 43 d post-implant. Phagocytic cells 
appeared to scavenge larger aggregates of AgNPs in control samples where silver 
content was known to be higher. Test samples contained less observable AgNPs and 
inflammatory cells displayed little reaction to the presence of smaller AgNP aggregates. 
Quantitative results from INAA in the experimental trial reinforced observations 
made with TEM. Silver was not detected within samples taken adjacent to the device 
with the coating that was hypothesized to not elute silver. A silver concentration of  
74 ppm ± 29% was measured in a sample taken adjacent to the control article that was 
known to elute silver. The relatively high error associated with this measurement was 
attributed to the noise generated by 
24
Na content of the sample during gamma ray 
spectroscopy. 
The Simulink
®
 model built to compute silver activation progeny inventories was 
used to relate the poor SNR encountered during feasibility and experimental trials to the 
657 keV 
110m
Ag and 1368 keV 
24
Na peak areas. The model showed that decay time 
following irradiation was the major factor predicting the ability to measure silver in 
biological matrices via INAA. 
In future work involving investigation of silver in these types of samples, it is 
recommended to increase activation time from 60 to 120 s to significantly increase the 
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intensity of the 657 keV 
110m
Ag peak relative to background. This would allow for a 
more specific measurement of the amount of silver present in samples with a lower limit 
of detectability. It is also recommended to increase decay time to 7 d to allow 
24
Na 
activity to almost completely deplete prior to measurement. Samples should also be 
dehydrated in multiple washes of ethanol prior to irradiation to reduce the amount of 
sodium in samples from fixative buffers. 
For true correlation between INAA and TEM, irradiated samples could be 
processed for TEM following gamma ray spectroscopy. Dehydrating samples in ethanol 
prior to irradiation would benefit this process since ethanol dehydration is required for 
TEM sample processing. Research should be performed to assess the safety of this 
technique, since this would require INAA laboratories to release radioactive material to 
TEM laboratories for handling and sample preparation. Total activity of biological 
samples containing silver should be measured over time after irradiation to assess 
whether handling these types of samples poses any danger to technicians. Increasing 
SNR with longer irradiation and decay times may decrease the amount of bulk sample 
needed to measure silver concentrations, also reducing total radioactivity of samples 
following irradiation. 
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